Literature DB >> 8832638

Olfactory dysfunction in Down's Syndrome.

C Murphy1, S Jinich.   

Abstract

Down's Syndrome subjects over 40 years old show neuropathology similar to that of Alzheimer's disease. The olfactory system is particularly vulnerable in Alzheimer's disease, both anatomically and functionally. Several measures of sensory and cognitive functioning were studied in the older Down's Syndrome patient, with the hypothesis of significant olfactory dysfunction. Participants were 23 Down's subjects, and 23 controls. The Dementia Rating Scale showed mean scores of 103 for Down's subjects and 141 for controls. Down's subjects showed significant deficits in odor detection threshold, odor identification, and odor recognition memory. Normal performance in a taste threshold task, similar to the olfactory threshold task in subject demands, suggested that the Down's syndrome subjects' poor performance was not due to task demands. Deficits in olfaction may provide a sensitive and early indicator of the deterioration and progression of the brain in older subjects with Down's Syndrome.

Entities:  

Mesh:

Year:  1996        PMID: 8832638     DOI: 10.1016/0197-4580(96)00008-5

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  10 in total

1.  Progressive Pathological Changes in Neurochemical Profile of the Hippocampus and Early Changes in the Olfactory Bulbs of Tau Transgenic Mice (rTg4510).

Authors:  Jieun Kim; In-Young Choi; Karen E Duff; Phil Lee
Journal:  Neurochem Res       Date:  2017-05-18       Impact factor: 3.996

2.  Olfactory deficits, cognition and negative symptoms in early onset psychosis.

Authors:  Cheryl Corcoran; Agnes Whitaker; Eliza Coleman; Jane Fried; Judith Feldman; Nora Goudsmit; Dolores Malaspina
Journal:  Schizophr Res       Date:  2005-08-26       Impact factor: 4.939

3.  Galantamine improves olfactory learning in the Ts65Dn mouse model of Down syndrome.

Authors:  Fabio M Simoes de Souza; Nicolas Busquet; Megan Blatner; Kenneth N Maclean; Diego Restrepo
Journal:  Sci Rep       Date:  2011-11-02       Impact factor: 4.379

4.  Modeling Down Syndrome with Patient iPSCs Reveals Cellular and Migration Deficits of GABAergic Neurons.

Authors:  Hai-Qin Huo; Zhuang-Yin Qu; Fang Yuan; Lixiang Ma; Lin Yao; Min Xu; Yao Hu; Jing Ji; Anita Bhattacharyya; Su-Chun Zhang; Yan Liu
Journal:  Stem Cell Reports       Date:  2018-03-08       Impact factor: 7.765

Review 5.  Olfaction and its alteration by nasal obstruction, rhinitis, and rhinosinusitis.

Authors:  R L Doty; A Mishra
Journal:  Laryngoscope       Date:  2001-03       Impact factor: 3.325

Review 6.  Development of Down Syndrome Research Over the Last Decades-What Healthcare and Education Professionals Need to Know.

Authors:  Karin Windsperger; Stefanie Hoehl
Journal:  Front Psychiatry       Date:  2021-12-14       Impact factor: 4.157

7.  Anosmin-1-Like Effect of UMODL1/Olfactorin on the Chemomigration of Mouse GnRH Neurons and Zebrafish Olfactory Axons Development.

Authors:  Elia Di Schiavi; Giulio Vistoli; Roberta Manuela Moretti; Ilaria Corrado; Giulia Zuccarini; Silvia Gervasoni; Lavinia Casati; Daniele Bottai; Giorgio Roberto Merlo; Roberto Maggi
Journal:  Front Cell Dev Biol       Date:  2022-02-11

8.  Overexpression of Uromodulin-like1 accelerates follicle depletion and subsequent ovarian degeneration.

Authors:  W Wang; Y Tang; L Ni; E Kim; T Jongwutiwes; A Hourvitz; R Zhang; H Xiong; H-C Liu; Z Rosenwaks
Journal:  Cell Death Dis       Date:  2012-11-29       Impact factor: 8.469

9.  Olfaction in People with Down Syndrome: A Comprehensive Assessment across Four Decades of Age.

Authors:  Maria Paola Cecchini; Dario Viviani; Marco Sandri; Antje Hähner; Thomas Hummel; Carlo Zancanaro
Journal:  PLoS One       Date:  2016-01-05       Impact factor: 3.240

Review 10.  Age-Related Olfactory Dysfunction: Epidemiology, Pathophysiology, and Clinical Management.

Authors:  Kenji Kondo; Shu Kikuta; Rumi Ueha; Keigo Suzukawa; Tatsuya Yamasoba
Journal:  Front Aging Neurosci       Date:  2020-07-07       Impact factor: 5.750

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.